We are live on ! Find out more
AHCO icon

AdaptHealth

38 hedge funds and large institutions have $204M invested in AdaptHealth in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 6

50% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 6

36% more capital invested

Capital invested by funds: $150M → $204M (+$54.4M)

31% more funds holding

Funds holding: 2938 (+9)

16.8% more ownership

Funds ownership: 47.32%64.12% (+17%)

Holders
38
Holders Change
+9
Holders Change %
+31.03%
% of All Funds
0.83%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
9
Reduced
6
Closed
6
Calls
$2.54M
Puts
Net Calls
+$2.54M
Net Calls Change
+$2.27M

AHCO Hedge Fund Activity: Q3 2019 in Review

38 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q3 2019, worth a combined $204M — up 36% from $150M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AHCO positions and 6 closed out — a net gain of 9 holders — while 9 added to existing stakes and 6 trimmed.

The largest buyer was Glazer Capital LLC, adding an estimated $22.2M. The largest seller was Highbridge Capital Management, exiting entirely with an estimated $20.3M sold.

  • 38 institutional investors held AdaptHealth (AHCO) as of Q3 2019, up from 29 in Q2 2019.
  • Funds reported $204M of AdaptHealth stock for Q3 2019, up 36% quarter-over-quarter.
  • 15 funds opened new AdaptHealth positions in Q3 2019 and 6 closed out, a net change of +9 holders.
  • The largest AdaptHealth buyer in Q3 2019 was Glazer Capital LLC, an estimated $22.2M added.
  • The largest AdaptHealth seller in Q3 2019 was Highbridge Capital Management, an estimated $20.3M sold.

Based on aggregated 13F filings for Q3 2019.